About this product
The serving provides 250 mg of Indian frankincense extract identified with boswellic acids. The focused formula avoids unrelated active ingredients and supplies a practical 60-serving bottle.
Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.
Boswellic-acid concentration, AKBA level, and enhanced delivery are not disclosed, limiting confidence in the modest serving. The 60-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.
Pros
The focused formula avoids unrelated active ingredients and supplies a practical 60-serving bottle 60 servings per container Single-ingredient design keeps the purpose clear
Cons
Boswellic-acid concentration, AKBA level, and enhanced delivery are not disclosed, limiting confidence in the modest serving. Single-botanical scope does not cover cartilage structure or joint lubrication. Serving value is less competitive than the more economical focused options.
Warnings
Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review. Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed. A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.
